Pablo Umaña

机构：Roche (Switzerland) · ORCID：0000-0001-8206-2771

发表论文 585 篇 · 总被引 13025 次 · h-index 52

代表论文

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial (2026 · Nature Medicine · 被引 6)
P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy (2025 · mAbs · 被引 4)
Molecular features of response and resistance to glofitamab, a T-cell engager for treatment of large B-cell lymphoma (2026 · Blood Advances · 被引 2)
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors (2026 · Clinical Cancer Research · 被引 1)